#fda advisory

Moderna's mRNA-based flu vaccine, mFLUSIVA (mRNA-1010), is facing a pivotal moment with the U.S. Food and Drug Administration (FDA) advisory committee, marking a significant step in the expansion of mRNA technology beyond COVID-19. This development u